Lee SD, Choe JW, Lee BJ, Kang MH, Joo MK, Kim JH, Yeon JE, Park JJ, Kim JS, Bak YT. Butein effects in colitis and interleukin-6/signal transducer and activator of transcription 3 expression. World J Gastroenterol 2015; 21(2): 465-474 [PMID: 25593461 DOI: 10.3748/wjg.v21.i2.465]
Corresponding Author of This Article
Beom Jae Lee, MD, PhD, Division of Gastroenterology, Department of Internal Medicine, Korea University Medical Center, 97 Gurodong-gil, Guro-gu, Seoul 152-703, South Korea. l85210@medimail.co.kr
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Basic Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Lee SD, Choe JW, Lee BJ, Kang MH, Joo MK, Kim JH, Yeon JE, Park JJ, Kim JS, Bak YT. Butein effects in colitis and interleukin-6/signal transducer and activator of transcription 3 expression. World J Gastroenterol 2015; 21(2): 465-474 [PMID: 25593461 DOI: 10.3748/wjg.v21.i2.465]
World J Gastroenterol. Jan 14, 2015; 21(2): 465-474 Published online Jan 14, 2015. doi: 10.3748/wjg.v21.i2.465
Butein effects in colitis and interleukin-6/signal transducer and activator of transcription 3 expression
Sehe Dong Lee, Jung Wan Choe, Beom Jae Lee, Myoung Hee Kang, Moon Kyung Joo, Ji Hoon Kim, Jong Eun Yeon, Jong-Jae Park, Jae Seon Kim, Young-Tae Bak
Sehe Dong Lee, Jung Wan Choe, Beom Jae Lee, Myoung Hee Kang, Moon Kyung Joo, Ji Hoon Kim, Jong Eun Yeon, Jong-Jae Park, Jae Seon Kim, Young-Tae Bak, Division of Gastroenterology, Department of Internal Medicine, Korea University Medical Center, Seoul 152-703, South Korea
Author contributions: Lee SD and Choe JW contributed equally to this work; Lee BJ designed the study and performed the majority of the experiments; Lee SD, Choe JW, Kang MH, Joo MK, Kim JH, Yeon JE, Park JJ, Kim JS and Bak YT were involved in editing the manuscript; Lee SD and Choe JW wrote the paper.
Supported by Grants from the National Research Foundation of Korea, No. R1102452; Korea University, No. K1220161; and by experimental techniques from the Core Laboratory for Convergent Translational Research of College of Medicine.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Beom Jae Lee, MD, PhD, Division of Gastroenterology, Department of Internal Medicine, Korea University Medical Center, 97 Gurodong-gil, Guro-gu, Seoul 152-703, South Korea. l85210@medimail.co.kr
Telephone: +82-2-26263004 Fax: +82-2-8531943
Received: April 14, 2014 Peer-review started: April 15, 2014 First decision: May 13, 2014 Revised: June 8, 2014 Accepted: July 11, 2014 Article in press: July 11, 2014 Published online: January 14, 2015 Processing time: 278 Days and 18.5 Hours
Abstract
AIM: To evaluate the effects of butein on inflammatory cytokines, matrix metalloproteinase-9 (MMP-9), and colitis in interleukin (IL)-10-/- mice.
METHODS: To synchronize colitis, 8- to 10-wk-old IL-10-/- mice were fed pellet-chow containing piroxicam for 2 wk. Subsequently, phosphate-buffered saline or butein (1 mg/kg per day, ip) was injected for 4 wk. Histologic scores, inflammatory cytokines, MMP-9 and phosphorylated signal transducer and activator of transcription 3 (pSTAT3) expressions were analyzed in IL-10-/- mice and in Colo 205 cells.
RESULTS: Butein reduced the colonic inflammatory score by > 50%. Expression levels of IL-6, IL-1β, interferon (IFN)-γ and MMP-9 were decreased in the colons of mice exposed to butein, whereas other inflammatory cytokines (IL-17A, IL-21 and IL-22) were unchanged. Immunohistochemical staining for pSTAT3 and MMP-9 was significantly decreased in the butein-treated groups compared with the controls. Butein inhibited IL-6-induced activation of STAT3 in Colo 205 cells.
CONCLUSION: Butein ameliorated colitis in IL-10-/- mice by regulating IL-6/STAT3 and MMP-9 activation.
Core tip: This study examined if butein, a naturally derived substance, has therapeutic effects in an animal model of inflammatory bowel disease, interleukin (IL)-10-/- mice. The results show that butein suppressed bowel inflammation and interfered with the IL-6/signal transducer and activator of transcription 3 and matrix metalloproteinase-9 pathways, suggesting that butein should be used to treat bowel inflammation-induced colon cancer. Although there have been several in vitro studies on tumor cells, there have been no in vivo studies examining the effect of butein on colitis in mice.
